These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28747430)

  • 21. Iron overload induced by IRP2 gene knockout aggravates symptoms of Parkinson's disease.
    Ci YZ; Li H; You LH; Jin Y; Zhou R; Gao G; Hoi MPM; Wang C; Chang YZ; Yu P
    Neurochem Int; 2020 Mar; 134():104657. PubMed ID: 31904393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification.
    Santos MCFD; Anderson CP; Neschen S; Zumbrennen-Bullough KB; Romney SJ; Kahle-Stephan M; Rathkolb B; Gailus-Durner V; Fuchs H; Wolf E; Rozman J; de Angelis MH; Cai WM; Rajan M; Hu J; Dedon PC; Leibold EA
    Nat Commun; 2020 Jan; 11(1):296. PubMed ID: 31941883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments.
    Zumbrennen-Bullough KB; Becker L; Garrett L; Hölter SM; Calzada-Wack J; Mossbrugger I; Quintanilla-Fend L; Racz I; Rathkolb B; Klopstock T; Wurst W; Zimmer A; Wolf E; Fuchs H; Gailus-Durner V; de Angelis MH; Romney SJ; Leibold EA
    PLoS One; 2014; 9(6):e98072. PubMed ID: 24896637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDX2, an iron-sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cells.
    Miyahara S; Ohuchi M; Nomura M; Hashimoto E; Soga T; Saito R; Hayashi K; Sato T; Saito M; Yamashita Y; Shimada M; Yaegashi N; Yamada H; Tanuma N
    J Biol Chem; 2024 Sep; 300(9):107678. PubMed ID: 39151727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide inhibits the degradation of IRP2.
    Wang J; Chen G; Pantopoulos K
    Mol Cell Biol; 2005 Feb; 25(4):1347-53. PubMed ID: 15684386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferredoxin reductase: pharmacogenomic assessment in colorectal cancer.
    Yu J; Marsh S; Ahluwalia R; McLeod HL
    Cancer Res; 2003 Oct; 63(19):6170-3. PubMed ID: 14559799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network Analysis Identifies Mitochondrial Regulation of Epidermal Differentiation by MPZL3 and FDXR.
    Bhaduri A; Ungewickell A; Boxer LD; Lopez-Pajares V; Zarnegar BJ; Khavari PA
    Dev Cell; 2015 Nov; 35(4):444-57. PubMed ID: 26609959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
    Ghosh MC; Tong WH; Zhang D; Ollivierre-Wilson H; Singh A; Krishna MC; Mitchell JB; Rouault TA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):12028-33. PubMed ID: 18685102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide.
    Styś A; Galy B; Starzyński RR; Smuda E; Drapier JC; Lipiński P; Bouton C
    J Biol Chem; 2011 Jul; 286(26):22846-54. PubMed ID: 21566147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron-independent phosphorylation of iron regulatory protein 2 regulates ferritin during the cell cycle.
    Wallander ML; Zumbrennen KB; Rodansky ES; Romney SJ; Leibold EA
    J Biol Chem; 2008 Aug; 283(35):23589-98. PubMed ID: 18574241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferredoxin reductase regulates proliferation, differentiation, cell cycle and lipogenesis but not apoptosis in SZ95 sebocytes.
    Li MT; Pi XX; Cai XL; Liu S; Huang Z; Zouboulis CC; Fan YM; Shi G
    Exp Cell Res; 2021 Aug; 405(2):112680. PubMed ID: 34090862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy.
    Peng Y; Shinde DN; Valencia CA; Mo JS; Rosenfeld J; Truitt Cho M; Chamberlin A; Li Z; Liu J; Gui B; Brockhage R; Basinger A; Alvarez-Leon B; Heydemann P; Magoulas PL; Lewis AM; Scaglia F; Gril S; Chong SC; Bower M; Monaghan KG; Willaert R; Plona MR; Dineen R; Milan F; Hoganson G; Powis Z; Helbig KL; Keller-Ramey J; Harris B; Anderson LC; Green T; Sukoff Rizzo SJ; Kaylor J; Chen J; Guan MX; Sellars E; Sparagana SP; Gibson JB; Reinholdt LG; Tang S; Huang T
    Hum Mol Genet; 2017 Dec; 26(24):4937-4950. PubMed ID: 29040572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
    Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
    J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo.
    Meyron-Holtz EG; Ghosh MC; Rouault TA
    Science; 2004 Dec; 306(5704):2087-90. PubMed ID: 15604406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors.
    Zhang J; Xu E; Ren C; Yan W; Zhang M; Chen M; Cardiff RD; Imai DM; Wisner E; Chen X
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18637-42. PubMed ID: 25512531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
    Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
    Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis.
    Sheftel AD; Stehling O; Pierik AJ; Elsässer HP; Mühlenhoff U; Webert H; Hobler A; Hannemann F; Bernhardt R; Lill R
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11775-80. PubMed ID: 20547883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development.
    Smith SR; Ghosh MC; Ollivierre-Wilson H; Hang Tong W; Rouault TA
    Blood Cells Mol Dis; 2006; 36(2):283-7. PubMed ID: 16480904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron regulatory protein 2 deficiency may correlate with insulin resistance.
    Zhou Y; Wu W; Xu Z; Liu Y; Chang H; Yu P; Zhang X; Yang Y; Liu K; Chang Y
    Biochem Biophys Res Commun; 2019 Mar; 510(2):191-197. PubMed ID: 30685084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron regulatory protein 2 turnover through a nonproteasomal pathway.
    Chang AH; Jeong J; Levine RL
    J Biol Chem; 2011 Jul; 286(27):23698-707. PubMed ID: 21558272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.